CASI Pharmaceuticals

SEC Filings

SEC Filings

View all SEC filings, View only Section 16 SEC filings
Please note that the above are links to www.sec.gov, a third-party web site. CASI Pharmaceuticals, Inc. does not maintain nor provide any information directly to www.sec.gov, and therefore makes no representations or warranties regarding the information contained therein. Further, CASI Pharmaceuticals, Inc. takes no responsibility for supplementing, updating, or correcting any information found on www.sec.gov.

Financial Reports

Date Form Description Web XBRL
November 14, 2017 10-Q Quarterly Report
August 14, 2017 10-Q Quarterly Report
May 15, 2017 10-Q Quarterly Report
March 31, 2017 10-K Annual Report
November 14, 2016 10-Q Quarterly Report
August 15, 2016 10-Q Quarterly Report
May 13, 2016 10-Q Quarterly Report
March 28, 2016 10-K Annual Report
November 13, 2015 10-Q Quarterly Report
August 14, 2015 10-Q Quarterly Report
May 15, 2015 10-Q Quarterly Report

In order to read our interactive data filings, you will need an XBRL viewer such as the viewer provided by the SEC at www.SEC.gov.

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More

In the News

CASI's turnaround turns eastward; firm seeks to be Celgene of China

Read Article →

Poster

Clinical Safety and Efficacy of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated, Locally Advanced or Metastatic Triple-Negative Breast Cancer

Download →

Poster

Rodman & Renshaw 19th Annual Global Investment Conference

Download →